Jazz Pharmaceuticals (JAZZ) News Today $109.64 +1.14 (+1.05%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$109.69 +0.05 (+0.05%) As of 06/16/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JAZZ Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period 15,296 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Ritholtz Wealth ManagementRitholtz Wealth Management bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 15,296 shares of the specialty pharmaJune 17 at 3:51 AM | marketbeat.comSG Americas Securities LLC Purchases New Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)SG Americas Securities LLC purchased a new stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 9,445 shares of the specialty pharmaceutical compaJune 17 at 3:27 AM | marketbeat.com5,050 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Purchased by New England Research & Management Inc.New England Research & Management Inc. acquired a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,050 shares of the specialJune 14 at 6:28 AM | marketbeat.comNew Century Financial Group LLC Invests $388,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)New Century Financial Group LLC acquired a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,125 shares of the specialty pharmaceutical company's stock,June 14 at 6:11 AM | marketbeat.comStifel Nicolaus Remains a Buy on Jazz Pharmaceuticals (JAZZ)June 13, 2025 | theglobeandmail.comRaymond James Keeps Their Hold Rating on Jazz Pharmaceuticals (JAZZ)June 13, 2025 | theglobeandmail.comCX Institutional Purchases Shares of 34,768 Jazz Pharmaceuticals plc (NASDAQ:JAZZ)CX Institutional purchased a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 34,768 shares of the specialty pharmaceutical company's stock, valued at approxJune 12, 2025 | marketbeat.comMerit Financial Group LLC Purchases New Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Merit Financial Group LLC purchased a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 2,265 shares of the specialty pharmaceutical coJune 12, 2025 | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)June 12, 2025 | americanbankingnews.comJazz Pharmaceuticals Releases Unexpected Phase 4 Results Highlighting Xywav®June 11, 2025 | msn.comJazz Pharmaceuticals' (JAZZ) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $202.00 price objective on shares of Jazz Pharmaceuticals in a report on Wednesday.June 11, 2025 | marketbeat.comUSA Financial Formulas Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)USA Financial Formulas purchased a new stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,710 shares of the specialty pharmaceJune 11, 2025 | marketbeat.comFirst Citizens Bank & Trust Co. Purchases New Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)First Citizens Bank & Trust Co. acquired a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 2,561 shares of the specialty pharmaceutical companyJune 11, 2025 | marketbeat.comHER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020-2034) | DelveInsightJune 10, 2025 | finance.yahoo.comZepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung CancerJune 10, 2025 | prnewswire.comJazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025June 9, 2025 | prnewswire.comRange Financial Group LLC Takes Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Range Financial Group LLC purchased a new stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 7,385 shares of the specialty pharmaceuticalJune 9, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wedge Capital Management L L P NCWedge Capital Management L L P NC cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 1.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 239,868 shares of the specialty pharmaceutical company's stock after selling 3,137 shares durinJune 8, 2025 | marketbeat.comRhumbline Advisers Has $20.43 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Rhumbline Advisers reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 1.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 164,556 shares of the specialty pharmaceutical companyJune 7, 2025 | marketbeat.comGAMMA Investing LLC Grows Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)GAMMA Investing LLC grew its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 20,224.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 126,012 shares of the specialty pharmaceutical coJune 7, 2025 | marketbeat.comNanotechnology in Cancer Treatment Market Positioned for Transformational Growth by 2029June 5, 2025 | finance.yahoo.comInsider Selling: Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Sells 500 Shares of StockJazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) CEO Bruce C. Cozadd sold 500 shares of the business's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $107.90, for a total transaction of $53,950.00. Following the sale, the chief executive officer now directly owns 438,473 shares of the company's stock, valued at approximately $47,311,236.70. The trade was a 0.11% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.June 5, 2025 | marketbeat.comTD Cowen Remains a Buy on Jazz Pharmaceuticals (JAZZ)June 5, 2025 | theglobeandmail.comBruce C. Cozadd Sells 500 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) StockJune 5, 2025 | insidertrades.comLmcg Investments LLC Increases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Lmcg Investments LLC lifted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 63.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 74,370 shares of the specialty pharmaceutical company's stock after purchasing an additional 28,907 shares dJune 5, 2025 | marketbeat.comWellington Management Group LLP Sells 3,026 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Wellington Management Group LLP trimmed its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 6.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,803 shares of the specialty pharmaceJune 4, 2025 | marketbeat.comJazz Pharmaceuticals' (JAZZ) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $202.00 price target on shares of Jazz Pharmaceuticals in a report on Tuesday.June 3, 2025 | marketbeat.comJazz Pharmaceuticals plc (JAZZ)’s Zepzelca Combo Boosts Survival in ES-SCLCJune 3, 2025 | insidermonkey.com2 Healthcare Stocks to Keep an Eye On and 1 to Turn DownJune 2, 2025 | msn.comJazz Pharmaceuticals succeeds in late-stage study of lung cancer treatmentJune 2, 2025 | msn.comJazz Pharmaceuticals Announces Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Significantly Improves Survival as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung CancerJune 2, 2025 | prnewswire.comJazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera® (zanidatamab-hrii) in First-Line HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ASCO 2025June 2, 2025 | prnewswire.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesJazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fourteen ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating on the compJune 2, 2025 | marketbeat.comWhat is Zacks Research's Forecast for JAZZ Q2 Earnings?Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) - Analysts at Zacks Research issued their Q2 2025 earnings estimates for shares of Jazz Pharmaceuticals in a research report issued to clients and investors on Tuesday, May 27th. Zacks Research analyst S. Ganoria anticipates that the specialtyMay 31, 2025 | marketbeat.comMassMutual Private Wealth & Trust FSB Increases Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 104.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 36,326 shares of the specialty pharmaceutical compMay 31, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Mackenzie Financial CorpMackenzie Financial Corp increased its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 493.3% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 20,286 shares of the specialty pharmaceutical company's stock after acMay 31, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Centre Asset Management LLCCentre Asset Management LLC cut its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 6.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 70,692 shares of the specialty pharmaceutical company's stock after sellingMay 30, 2025 | marketbeat.comJazz Pharmaceuticals to Present Expansive Research Demonstrating Comprehensive Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) in Sleep Conditions and Associated Comorbidities at SLEEP 2025May 29, 2025 | prnewswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 15,142 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 8.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 189,220 shares oMay 29, 2025 | marketbeat.comWoodline Partners LP Sells 201,644 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Woodline Partners LP cut its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 72.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 77,564 shares of the speciMay 25, 2025 | marketbeat.comTwo Sigma Advisers LP Has $10.06 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Two Sigma Advisers LP lessened its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 22.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 81,700 shares of the specialty pharmaceutical company's stocMay 25, 2025 | marketbeat.comCetera Investment Advisers Buys New Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Cetera Investment Advisers bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 10,092 shares of the specialty pharmaceutical company's stock, valued at apMay 25, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP decreased its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 41.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 187,126 shares of the specMay 24, 2025 | marketbeat.comTidal Investments LLC Boosts Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Tidal Investments LLC boosted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 14.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,905 shares of the specialty pharmaceutiMay 24, 2025 | marketbeat.comMan Group plc Has $3.33 Million Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Man Group plc raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 22.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,075 shares of the specialty pharmaceutical company's stock after buyingMay 24, 2025 | marketbeat.comMidWestOne Financial Group Inc. Grows Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MidWestOne Financial Group Inc. lifted its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 10.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,347 shares of the specialty pharmaceuticalMay 23, 2025 | marketbeat.comNomura Holdings Inc. Increases Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Nomura Holdings Inc. grew its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 218.3% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 8,022 shares of the specialty pharmaceutical company's stock after buying an additional 5,502 shares dMay 22, 2025 | marketbeat.comFocus Partners Wealth Buys Shares of 4,469 Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Focus Partners Wealth bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 4,469 shares of the specialty pharmaceutiMay 22, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Position Cut by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC decreased its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 98.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 449 shares of the specialty pharmaceutical company's stockMay 22, 2025 | marketbeat.comJazz Pharmaceuticals to Participate in Upcoming June Investor ConferencesMay 21, 2025 | prnewswire.com Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address JAZZ Media Mentions By Week JAZZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAZZ News Sentiment▼1.000.90▲Average Medical News Sentiment JAZZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAZZ Articles This Week▼1512▲JAZZ Articles Average Week Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News CORT News PRGO News SUPN News NKTR News PCRX News OMER News ASMB News CPIX News LLY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAZZ) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JAZZ Stock Free JAZZ Stock Alerts